Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Atrial Flutter

• A Study to Evaluate Accuracy and Validity of the Chang Gung ECG Abnormality Detection Software
• Diltiazem in the Treatment of Atrial Fibrillation or Atrial Flutter With Rapid Ventricular Rate
• Refralon in Patients With Recurrence Paroxysmal and Persistent Forms of Atrial Fibrillation and Atrial Flutter Who Underwent Catheter Ablation
• Effect of Oral and Intravenous Diltiazem Protocol for Emergency Department Atrial Fibrillation
• What is the Optimal Antithrombotic Strategy in Patients Presenting With Acute Coronary Syndrome Having Atrial Fibrillation With Indication for Anticoagulants?
• Comparison of Bolus Dosing of Methohexital and Propofol in Elective Direct Current Cardioversion
• Bolus vs IVP (Intravenous Push) Diltiazem for Atrial Fibrillation or Flutter
• Half-normal Saline in Atrial Flutter Ablation
• The Danish Warfarin-Dialysis Study - Safety and Efficacy of Warfarin in Patients With Atrial Fibrillation on Dialysis
• Oral vs Intravenous Diltiazem for Rapid Atrial Fibrillation/Flutter Trial
• Colchicine For The Prevention Of Perioperative Atrial Fibrillation In Patients Undergoing Thoracic Surgery (COP-AF)
• Start or STop Anticoagulants Randomised Trial (SoSTART)
• Prospective Randomized Clinical Trial of Fetal Atrial Flutter & Supraventricular Tachycardia Therapy (FAST RCT)
• INR Control and Atrial Fibrillation in Primary Care in Spain (PAULA)
• Resolution of Left Atrial-Appendage Thrombus - Effects of Dabigatran in Patients With AF
• Therapy of Atrial Flutter by Afib Ablation
• Randomized Trial Comparing Diltiazem and Metoprolol For Atrial Fibrillation Rate Control
• Radiofrequency Ablation Plus Botulinum Toxin Injection Versus Radiofrequency Ablation Only in Patients With Atrial Flutter
• Use of Dabigatran Etexilate to Prevent Stroke and Thromboembolism
• Genetically Targeted Therapy for the Prevention of Symptomatic Atrial Fibrillation in Patients With Heart Failure
• Comparison of Diltiazem and Metoprolol in the Management of Acute Atrial Fibrillation or Atrial Flutter
• Exploring the Efficacy of Once Daily Oral Rivaroxaban for Treatment of Thrombus in Left Atrial/Left Atrial Appendage in Subjects With Nonvalvular Atrial Fibrillation or Atrial Flutter
• Potassium Infusion for Conversion of Atrial Fibrillation/-Flutter
• Safety and Efficacy of Vanoxerine for Conversion of Atrial Fibrillation or Flutter to Normal Sinus Rhythm
• Evaluate the Pharmacokinetics and Safety of MK-4448 in Participants With Nonvalvular Atrial Fibrillation or Atrial Flutter
• Prophylaxis to Reduce Postoperative Atrial Fibrillation in Cardiac Surgery
• Prevention of Atrial Fibrillation by Inhibition Conversion Enzyme (ICE) After Radiofrequency Ablation of Atrial Flutter
• Comparison of ATI-5923, a Novel Vitamin K Antagonist, With Warfarin in Patients Requiring Chronic Anticoagulation
• Cardiac Electrophysiological Study
• Combined Use of BIOTRONIK Home Monitoring and Predefined Anticoagulation to Reduce Stroke Risk
• A Phase II/III Tolerance and Efficacy Study of RSD1235 in Patients With Atrial Flutter
• Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
• Study of RSD1235-SR for the Prevention of Atrial Fibrillation/Atrial Flutter Recurrence
• EURopean Trial In Atrial Fibrillation(AF) or Flutter (AFL) Patients Receiving Dronedarone for the maIntenance of Sinus Rhythm (EURIDIS)
• American-Australian-African Trial With Dronedarone in Patients With Atrial Fibrillation or Atrial Flutter for the Maintenance of Sinus Rhythm
• Placebo Controlled Double-blind Dose Ranging Study of the Efficacy and Safety of SSR149744C 50, 100, 200 or 300 mg OD With Amiodarone as Calibrator for the Maintenance of Sinus Rhythm in Patients With Recent Atrial Fibrillation/Flutter
• Double Blind Placebo COntrolled Dose Ranging studY of the eFficacy and safEty of SSR149744c 300 or 600 mg for the Conversion of Atrial Fibrillation / fluttEr
• Use of Fish Oils to Prevent Atrial Mechanical Stunning and Atrial Remodeling Due to Atrial Arrhythmia
• A Trial With Dronedarone to Prevent Hospitalization or Death in Patients With Atrial Fibrillation
• Intravenous Tedisamil in the Rapid Conversion of Atrial Fibrillation or Flutter to Normal Sinus Rhythm in Female Subjects
• Intravenous Tedisamil in the Rapid Conversion of Atrial Fibrillation or Flutter to Normal Sinus Rhythm in Male Subjects
• Intravenous Tedisamil in the Rapid Conversion of Atrial Fibrillation or Flutter to Normal Sinus Rhythm in Female Subjects
• Response to RSD1235 Compared to Placebo in Subjects With Atrial Arrhythmia After Heart Surgery
• Study to Determine the Response and Effectiveness of RSD1235 in Subjects With Atrial Fibrillation or Atrial Flutter